Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

ALT-711 shows efficacy but fails to meet endpoints in SAPPHIRE and SILVER trials

July 18, 2003

NHE-3 inhibitors in early development at Merck KGaA

July 18, 2003

United Therapeutics files IND for i.v. Remodulin

July 15, 2003

Improved survival with carvedilol compared to metoprolol in chronic heart failure

July 15, 2003

Novel Wyeth compounds that increase HDL cholesterol

July 11, 2003

Vasogen initiates patient enrollment in pivotal ACCLAIM trial

July 10, 2003

Stent-induced restenosis reduced by inhibitor of PDGFR-TK

July 10, 2003

FDA advisory committee schedules Ranexa NDA for review

July 9, 2003

Pravastatin improves cardiovascular risk in women with coronary heart disease

July 8, 2003

Safer antiarrhythmic agents newly developed at ARYx

July 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...